The Innovative Medicines Initiative (IMI) is launching a major new project that will pioneer a novel, more flexible approach to clinical trials of drugs designed to prevent Alzheimer's disease. The €53 million project, which will see several biotechnology and pharmaceutical companies working closely together, will aim to speed up drug development and patient access to the latest treatments. The announcement comes as the UK hosts a G8 summit dedicated to dementia in London on 11 December.There is an urgent need for new treatments for Alzheimer's disease.
More...
More...